RECRUITING

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Description

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Conditions

Astigmatism
Talk to us

Related Conditions:

Astigmatism

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Evaluation of the Impact of Residual Astigmatism on the Visual Performance With Clareon Vivity

Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Condition
Astigmatism
Intervention / Treatment

-

Contacts and Locations

Bloomfield Hills

Grosinger, Spigelman & Grey Eye Surgeons, P.C, Bloomfield Hills, Michigan, United States, 48302

Dallas

Key-Whitman Eye Center, Dallas, Texas, United States, 75243

Sugar Land

Berkeley Eye Center, Sugar Land, Texas, United States, 77478

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Able to understand and sign an Institution Review Board-approved informed consent form;
  • * Willing and able to attend all scheduled study visits as required by the protocol;
  • * Implanted with study IOLs in both eyes at least 4 months prior to study participation;
  • * BCDVA of 0 logMAR or better in each eye.
  • * Residual astigmatism greater than or equal to 1.00 D;
  • * Clinically significant ocular conditions as specified in the protocol;
  • * History of ocular surgeries other than limbal relaxing incisions
  • * Other protocol-specified exclusion criteria may apply.

Ages Eligible for Study

22 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Alcon Research,

Clinical Trial Lead, Surgical CRD, STUDY_DIRECTOR, Alcon Research, LLC

Study Record Dates

2025-06